Investor Relations

Nanalysis Scientific Corp. will start trading on the TSX Venture Exchange (symbol NSCI) starting in June, 2019. The company has a 10 year history as a global developer and supplier of portable Nuclear Magnetic Resonance (NMR) spectrometers for the laboratory instrumentation market. In 2013, the company launched the industry-leading NMReady™-60, the first fully featured 60 MHz benchtop NMR spectrometer in a single compact enclosure requiring no liquid helium or other cryogens. The NMReady-60 is used for all types of industrial applications (oil & gas, chemical, pharma, biotech, food science, atomic agencies) and is a category leader in the academic teaching and research markets. In 2015, the company launched the NMReady-60PRO™, featuring multi-nuclear and hetero-nuclear 2D capabilities and targeting researchers and industrial laboratories doing complex chemical analysis. The company has sold instruments in over 40 countries and has been awarded the prestigious Frost & Sullivan award in 2016 and 2018 as the Company of the Year in the Global Portable NMR sector. The company sells direct in United States, Canada, and Germany, but sells via local distributors in countries such as UK, Japan, India, and roughly 40 territories.

Founded in 2009, Nanalysis Scientific Corp. is publicly traded on the TSX Venture Exchange (TSX.VENTURE:NSCI)

Exchange: TSX Venture Exchange
Ticker Symbol: NSCI
Transfer Agent: AST Trust Company (Canada)
Corporate Council: DLA Piper (Canada) LLP
Auditors: Crowe MacKay LLP

Contact Information

Phone: +1.587.899.0513
Email: ir@nanalysis.com



Investor presentation

Investor presentation

LINKS

Please visit us in Calgary at anytime!
If you can't visit us, perhaps watch this video to see inside the company, meet our great team and view some of our facility.